Exposure to Antibiotics May Affect Progression-Free Survival Negatively in NSCLC Patients Receiving First-Line Chemotherapy

被引：0
|
作者：
Tian, X.
Gong, Y.
Mei, T.
Yang, X.
Xu, Y.
Yu, M.
Li, Y.
Zhu, J.
Huang, M.
Zhang, Y.
Peng, F.
Zhou, L.
Zhou, X.
Xue, J.
Liu, Y.
Zou, B.
Wang, Y.
Lu, Y.
机构：
[1] Sichuan Univ, West China Hosp, Ctr Canc, Dept Thorac Oncol, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
NSCLC; first-line chemotherapy; antibiotics exposure;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P30.09
引用
收藏
页码：S397 / S398
页数：2
相关论文
共 50 条
  • [1] PROGRESSION-FREE SURVIVAL AND POSTPROGRESSION SURVIVAL IN PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY
    Shitara, K.
    Matsuo, K.
    Muro, K.
    Ohtsu, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 232 - 232
  • [2] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [3] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [4] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [5] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Kenji Hashimoto
    Atsuo Takashima
    Kengo Nagashima
    Shun-suke Okazaki
    Takako Eguchi Nakajima
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    [J]. Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1059 - 1064
  • [6] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Hashimoto, Kenji
    Takashima, Atsuo
    Nagashima, Kengo
    Okazaki, Shun-suke
    Nakajima, Takako Eguchi
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (07) : 1059 - 1064
  • [7] Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC
    Rutkowski, Jacek
    Saad, Everardo D.
    Burzykowski, Tomasz
    Buyse, Marc
    Jassem, Jacek
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : 1619 - 1627
  • [8] Analysis of factors affecting progression-free survival of first-line chemotherapy in older patients with advanced gastrointestinal cancer
    Nakazawa, Junichi
    Kawahira, Machiko
    Kawahira, Masahiro
    Kodama, Tomoko
    Arima, Shiho
    Iwashita, Yuji
    Mawatari, Seiji
    Hashimoto, Shinichi
    Kanmura, Shuji
    Hori, Takeshi
    Tsubouchi, Hirohito
    Ido, Akio
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (08) : 1200 - 1207
  • [9] Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy
    Emori, Tomoya
    Itonaga, Masahiro
    Ashida, Reiko
    Tamura, Takashi
    Kawaji, Yuki
    Hatamaru, Keiichi
    Yamashita, Yasunobu
    Shimokawa, Toshio
    Koike, Masataka
    Sonomura, Tetsuo
    Kawai, Manabu
    Kitano, Masayuki
    [J]. PANCREATOLOGY, 2022, 22 (02) : 277 - 285
  • [10] Progression-free survival in patients receiving first-line platinum-based therapy in Argentina: OCEANIA study.
    Abreu, Gabriela
    Queiroz, Juliana
    Nogueira, Thiago
    Soares, Claudia
    Menezes, Patricia
    Carrizo, Mariano Nicolas
    Criniti, Juan
    Felice, Rosana
    Scibona, Paula
    Simonovich, Ventura
    Riggi, Maria Cecilia
    Cravero, Florencia
    Odetto, Diego
    Saadi, Jose
    Jotimliansky, Laura Fabia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345